Today represents the third time this year that the House has considered legislation to deliver hope to patients who are battling terminal diseases. Twice already, a bipartisan majority of Members has supported increasing patient access to investigational drugs through a new pathway outside of the existing expanded access program, and the bill before us today is deserving of that same support. Thirty-nine States have right-to-try laws, including my home State of Oregon. While the State policies vary, they have a common goal: helping vulnerable patients. President Trump praised the movement during the State of the Union. He said: ``People who are terminally ill should not have to go from country to country to seek a cure. I want to give them a chance here at home.'' Those are the President's words. Since this time, he has continued to feverishly advocate for this legislation. For today's debate, I believe it is important to understand that it is both the background of this issue as well as the politics that have brought us back to this floor. Today, there is an existing process for patients to access unapproved drugs. The FDA oversees the expanded access program, commonly known as compassionate use. This program has been critical in helping patients access experimental or investigative drugs.…
Share
More from Greg Walden
The FCC Process Reform Act is bipartisan legislation that passed the House on March 11 of this year and would bring needed reforms to the commission's processes.
I want to thank my dear friend and colleague from Georgia (Mr. Carter) for his leadership on so many issues before the committee and for his very kind and generous words. I will miss serving with Mr. Carter. He has been a terrific member…
I, too, rise in support of H.R. 4499, the National Institute on Minority and Health Disparities Research Endowment Revitalization Act. Mr. Speaker, I thank my Committee on Energy and Commerce colleagues on both sides of the aisle…
Before I yield to the author of the bill, the gentleman from Texas, I can tell you, Texas has few stronger advocates, if any, than Mr. Olson. And Texas 22, his congressional district, has had an incredibly effective voice in the United…





